These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37146838)

  • 1. Simultaneous assessment of central nervous and respiratory systems using jacketed telemetry in socially-housed rats: Application of the "3Rs" principles in core battery safety pharmacology studies.
    Fares R; Champéroux P
    J Pharmacol Toxicol Methods; 2023; 121():107268. PubMed ID: 37146838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non invasive jacketed telemetry in socially-housed rats for a combined assessment of respiratory system, electrocardiogram and activity using the DECRO system.
    Fares R; Flénet T; Vial J; Ravaz M; Roger V; Bory C; Baudet S
    J Pharmacol Toxicol Methods; 2022; 117():107195. PubMed ID: 35779850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods.
    Redfern WS; Dymond A; Strang I; Storey S; Grant C; Marks L; Barnard C; Heys C; Moyser K; Greenwood K; Cobey D; Moore N; Karp NA; Prior H
    J Pharmacol Toxicol Methods; 2019; 98():106591. PubMed ID: 31146025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core battery safety pharmacology testing - An assessment of its utility in early drug development.
    Baldrick P
    J Pharmacol Toxicol Methods; 2021; 109():107055. PubMed ID: 33813006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.
    Ewart L; Milne A; Adkins D; Benjamin A; Bialecki R; Chen Y; Ericsson AC; Gardner S; Grant C; Lengel D; Lindgren S; Lowing S; Marks L; Moors J; Oldman K; Pietras M; Prior H; Punton J; Redfern WS; Salmond R; Skinner M; Some M; Stanton A; Swedberg M; Finch J; Valentin JP
    J Pharmacol Toxicol Methods; 2013; 68(1):30-43. PubMed ID: 23665080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOB vs modified Irwin: What are we doing?
    Gauvin DV; Zimmermann ZJ
    J Pharmacol Toxicol Methods; 2019; 97():24-28. PubMed ID: 30885703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benchmarking safety pharmacology regulatory packages and best practice.
    Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
    J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of effects detected in the rat functional observational battery following oral administration of non-CNS targeted compounds.
    Redfern WS; Strang I; Storey S; Heys C; Barnard C; Lawton K; Hammond TG; Valentin JP
    J Pharmacol Toxicol Methods; 2005; 52(1):77-82. PubMed ID: 15936219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated "Day 1" FOB testing in ICH S7A safety assessment protocols: The influence of within- and between-session learning.
    Gauvin DV; Zimmermann ZJ; Dalton JA; Baird TJ
    J Pharmacol Toxicol Methods; 2017; 85():61-72. PubMed ID: 28216425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Irwin Test and Functional Observational Battery (FOB) for Assessing the Effects of Compounds on Behavior, Physiology, and Safety Pharmacology in Rodents.
    Mathiasen JR; Moser VC
    Curr Protoc Pharmacol; 2018 Dec; 83(1):e43. PubMed ID: 30179315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telemetric assessment of social and single housing: Evaluation of electrocardiographic intervals in jacketed cynomolgus monkeys.
    Kaiser RA; Tichenor SD; Regalia DE; York K; Holzgrefe HH
    J Pharmacol Toxicol Methods; 2015; 75():38-43. PubMed ID: 25959881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison.
    Himmel HM; ; Delaunois A; Deurinck M; Dinklo T; Eriksson Faelker TM; Habermann C; Heers C; Hempel K; Lorenz H; Rosch A; Schauerte H; Teuns G; Traebert M; van Amsterdam C; van der Linde H
    J Pharmacol Toxicol Methods; 2019; 99():106571. PubMed ID: 30928509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
    Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
    J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat.
    Gauvin DV; Yoder JD; Holdsworth DL; Harter ML; May JR; Cotey N; Dalton JA; Baird TJ
    J Pharmacol Toxicol Methods; 2016; 82():90-108. PubMed ID: 27534836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of safety pharmacology.
    Goineau S; Lemaire M; Froget G
    Curr Protoc Pharmacol; 2013 Dec; 63():10.1.1-10.1.8. PubMed ID: 24510755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process.
    Jackson SJ; Authier S; Brohmann H; Goody SMG; Jones D; Prior H; Rosch A; Traebert M; Tse K; Valentin JP; Milne A
    J Pharmacol Toxicol Methods; 2019; 100():106602. PubMed ID: 31238094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a botanical composition, UP446, on respiratory, cardiovascular and central nervous systems in beagle dogs and rats.
    Yimam M; Lee YC; Jia Q
    Regul Toxicol Pharmacol; 2016 Jun; 77():184-91. PubMed ID: 27012374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of safety pharmacology.
    Porsolt RD
    Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.1. PubMed ID: 22294166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety pharmacology--current and emerging concepts.
    Hamdam J; Sethu S; Smith T; Alfirevic A; Alhaidari M; Atkinson J; Ayala M; Box H; Cross M; Delaunois A; Dermody A; Govindappa K; Guillon JM; Jenkins R; Kenna G; Lemmer B; Meecham K; Olayanju A; Pestel S; Rothfuss A; Sidaway J; Sison-Young R; Smith E; Stebbings R; Tingle Y; Valentin JP; Williams A; Williams D; Park K; Goldring C
    Toxicol Appl Pharmacol; 2013 Dec; 273(2):229-41. PubMed ID: 23732082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.